当前位置：
X-MOL 学术
›
EMBO Mol. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
EMBO Molecular Medicine ( IF 9.0 ) Pub Date : 2022-03-07 , DOI: 10.15252/emmm.202115618 Liping Ye , Chuyong Lin , Xi Wang , Qiji Li , Yue Li , Meng Wang , Zekun Zhao , Xianqiu Wu , Dongni Shi , Yunyun Xiao , Liangliang Ren , Yunting Jian , Meisongzhu Yang , Ruizhang Ou , Guangzheng Deng , Ying Ouyang , Xiangfu Chen , Jun Li , Libing Song
中文翻译：
SALL2的表观遗传沉默赋予乳腺癌他莫昔芬抗性
更新日期：2022-03-07
EMBO Molecular Medicine ( IF 9.0 ) Pub Date : 2022-03-07 , DOI: 10.15252/emmm.202115618 Liping Ye , Chuyong Lin , Xi Wang , Qiji Li , Yue Li , Meng Wang , Zekun Zhao , Xianqiu Wu , Dongni Shi , Yunyun Xiao , Liangliang Ren , Yunting Jian , Meisongzhu Yang , Ruizhang Ou , Guangzheng Deng , Ying Ouyang , Xiangfu Chen , Jun Li , Libing Song
中文翻译：
SALL2的表观遗传沉默赋予乳腺癌他莫昔芬抗性
京公网安备 11010802027423号